Pablo Lopez-Balboa

4PUBLICATIONS
18CO-AUTHORS
Infant and child healthNeonatologyRegenerative medicine (incl. stem cells)Electrochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 23, 2026
Intravenous gentamicin therapy in children with severe recessive dystrophic epidermolysis bullosa patients with nonsense COL7A1 mutations.

|Jun 04, 2026
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial.

|May 21, 2025
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension.

Maria L Bageta, Pablo López-Balboa, Munyaradzi Dimairo

|May 28, 2022
Hypotrichosis simplex of the scalp and peeling skin disease, two sides of the same coin.

P López-Balboa, L Martos-Cabrera, M Ramírez-Lluch

Pageof 1

Frequent Collaborators

2 joint publications

Gabriela Petrof

2 joint publications

Maria L Bageta

2 joint publications

Katie Biggs

2 joint publications

Diana Papaioannou